Notably, when NAMPT was depleted in salvage-dependent tumors, they were still able to maintain the NAD supply through the alternative salvage NR-NMRK1 pathway, and dual NMRK1 and NAMPT inhibition resulted in more effective NAD reduction and significant tumor suppression in vivo [37]. The gene discussed is NAMPT; the disease is neoplasm.